Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
Zimmermann FM, Ding VY, Pijls NHJ, Piroth Z, van Straten AHM, Szekely L, Davidavicius G, Kalinauskas G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Aminian A, Oldroyd KG, Al-Attar N, Jagic N, Dambrink JE, Kala P, Angeras O, MacCarthy P, Wendler O, Casselman F, Witt N, Mavromatis K, Miner SES, Sarma J, Engstrøm T, Christiansen EH, Tonino PAL, Reardon MJ, Otsuki H, Kobayashi Y, Hlatky MA, Mahaffey KW, Desai M, Woo YJ, Yeung AC, De Bruyne B, Fearon WF; FAME 3 Investigators. Zimmermann FM, et al. Among authors: otsuki h. Circulation. 2023 Sep 19;148(12):950-958. doi: 10.1161/CIRCULATIONAHA.123.065770. Epub 2023 Aug 21. Circulation. 2023. PMID: 37602376 Free article. Clinical Trial.
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial.
Kobayashi Y, Takahashi T, Zimmermann FM, Otsuki H, El Farissi M, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, De Bruyne B, Pijls NHJ, Fearon WF; FAME 3 Trial Investigators. Kobayashi Y, et al. Among authors: otsuki h. JACC Cardiovasc Interv. 2023 Sep 11;16(17):2112-2119. doi: 10.1016/j.jcin.2023.06.023. JACC Cardiovasc Interv. 2023. PMID: 37704297 Free article. Clinical Trial.
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy.
Otsuki H, Takahashi K, Zimmermann FM, Mavromatis K, Aminian A, Jagic N, Dambrink JE, Kala P, MacCarthy P, Witt N, Kobayashi Y, Takahashi T, Woo YJ, Yeung AC, De Bruyne B, Pijls NHJ, Fearon WF; FAME 3 Trial Investigators. Otsuki H, et al. Circ Cardiovasc Interv. 2024 Nov;17(11):e014300. doi: 10.1161/CIRCINTERVENTIONS.124.014300. Epub 2024 Nov 6. Circ Cardiovasc Interv. 2024. PMID: 39502029 Clinical Trial.
Sex Differences in Patients Undergoing FFR-Guided PCI or CABG in the FAME 3 Trial.
Takahashi K, Otsuki H, Zimmermann FM, Ding VY, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B, Fearon WF; FAME 3 Trial Investigators. Takahashi K, et al. Among authors: otsuki h. JACC Cardiovasc Interv. 2024 Nov 11:S1936-8798(24)01217-2. doi: 10.1016/j.jcin.2024.09.030. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 39641725
Mismatch Between Residual Mitral Regurgitation and Left Atrial Pressure Predicts Prognosis After Transcatheter Edge-to-Edge Repair.
Shibahashi E, Yamaguchi J, Kawamoto T, Yoshikawa M, Kogure T, Inagaki Y, Koyanagi C, Otsuki H, Yamamoto M, Saji M, Kubo S, Asami M, Nakashima M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Otsuka T, Hayashida K; OCEAN-Mitral Investigators. Shibahashi E, et al. Among authors: otsuki h. JACC Cardiovasc Interv. 2024 Sep 23;17(18):2126-2137. doi: 10.1016/j.jcin.2024.07.046. JACC Cardiovasc Interv. 2024. PMID: 39322363
171 results